Washington, D.C. (MMD Newswire) February 3, 2012 — You are invited to a Business Forum on Lithuanian-American partnership, on February 16, 2012 at the Mayflower Hotel, Washington, D.C.

The Business Forum will feature a keynote address by the Minister of Economy of the Republic of Lithuania, Mr. Rimantas Žylius.

The Forum will focus on trade promotion by cutting transportation costs and saving time trading with Europe and Asia, business opportunities in Lithuania’s energy sector as well as opportunities for investment in other areas.

Speakers at the forum will include (from 1:00 to 5:00 pm):

-  Rebecca BLANK, Deputy Secretary of the U.S. Department of Commerce (invited)

-  Martin J. BERARDI, President, Moog Medical Devices Group, Moog Inc.

-  Woody LANGDON, Director of Business Strategy Market Intelligence World Sourcing Capabilities, Computer Sciences Corporation

-  William KENWELL, Sr. Vice President and Chief Commercial Officer, MAERSK Line, Ltd (invited)

-  Hiroto UOZUMI, President, Hitachi-GE Nuclear Energy, Ltd.

-  Takashi HATCHOJI, Chairman, Hitachi America Ltd.

For more information contact the Embassy of Lithuania in Washington, D.C. at (202) 234 5860 ext 118 or rolandas.kacinskas@urm.lt.

***

Lithuania is attractive to U.S. companies for a number of reasons. It is a gateway to markets in the East, and into the wider European Union. Lithuanian industry is a leader in many interesting areas, including laser technology. Its workforce is well-educated. The nation’s transportation sector is modern, along with its legal system. Lithuania’s leadership has enabled it to emerge from economic crisis to becoming one of the fastest growing economies in the European Union – it grew by 5.8 percent in 2011. The US trade with Lithuania is also growing rapidly, reflecting the economic recovery. Lithuania’s leadership encourages American companies to look at Lithuania. A steadfast ally, and a friend, Lithuania has much to offer.

Article source: Source

Emily Downing, attorney at Lewis Lewis P.C., in Buffalo, New York, has settled a dog bite case for $65,000.

February 3, 2012 (MMD Newswire) — Because of the potential severity of a dog bite, victims of dog bites are advised to seek medical attention immediately. Downing explained that in her most recent case, there was serious physical, mental, and emotional damage caused by the dog bite.

“The individual had 11 stitches and post-traumatic stress disorder,” said Downing. “Though we won’t be able to take away the victim’s physical pain, we’re hoping that this will be a psychological win for them. Our client has a long road of recovery ahead of them, and this will hopefully make that journey a little easier.”

Anyone who has been attacked by a dog is urged to also seek assistance from one of their New York dog bite attorneys without delay to determine if they have a legal case.

Lewis Lewis P.C. has been assisting injured individuals since 1944. Since then, Lewis Lewis P.C. has transformed into the largest combined workers’ compensation and personal injury attorney firm in Western New York.

###

Article source: Source

SAN DIEGO, CA (MMD Newswire) February 3, 2012 — Medical Marijuana Inc (OTC: MJNA) is pleased to announce the results for its quarter ending December 31, 2011.

The company’s revenue increased in excess of 115% over the prior quarter from $198,812.60 to $430,139.36. Since the close of the first quarter 2011, to the close of the fourth quarter 2011, company revenues have increased an accumulative 3941%, and quarter over quarter since the first quarter 2011 have had a compounded quarterly increase of 101%. This increase comes from its subsidiary Wellness Managed Services, which engages in the management and development of Health and Wellness facilities and hydroponics stores throughout North America.

“We are very pleased with our year end results; we have had new management in place for just over eight months and have seen very strong growth. However, we did have some setbacks at the beginning of the third quarter and we were able to resolve those at the end of the fourth quarter. We anticipate having significant growth throughout 2012 with the development of Wellness Managed Services as well as the commercialization of our much anticipated Hemp Compounds business, which has focused on the research, development and sales of hemp extracts for the pharmaceutical and nutraseutical industries. It is also important to point out that for the first time since the company’s inception it has stabilized its operating costs and with its additional growth from Wellness Managed Services and the launch of Hemp Compounds that should all add to our bottom line.” Quote stated by Michael Llamas, President of Medical Marijuana Inc.

ABOUT MEDICAL MARIJUANA INC

Medical Marijuana Inc. (“MJNA”) is the first publicly held company vested in the medical marijuana and industrial hemp industries. Our mission is to be the world’s premier cannabis and hemp industry innovators, leveraging our team of professionals to source, evaluate, invest in and purchase value-added sustainable companies, while allowing them to keep their integrity and entrepreneurial spirit. We strive to create awareness within our industry, pay homage to the visionaries and activists of the past and present, and provide the platform from which the industry can emerge into a global sustainable economy for all. Medical Marijuana Inc recognizes the vast and unequaled opportunities that exist in the rapidly expanding hemp and medical marijuana industries. The scientific recognition of cannabis has brought legalized marijuana use to the forefront of mainstream discussion, thus opening the door for safe and lucrative investment opportunities. www.medicalmarijuanainc.com

FORWARD-LOOKING DISCLAIMER

This press release may contain certain forward-looking statements and information, as defined within the meaning of

Article source: Source

W. SPRINGFIELD, MA (MMD Newswire) February 1, 2012 — 2012 marks the 30th year of operation for MTI Systems Inc.,(http://www.mtisystems.com)the leading provider of innovative cost estimating software solutions for manufacturing. The company’s flagship product, Costimator, has been implemented by over 1,400 companies in 22 countries since 1982.

Founded in 1982 as Manufacturers Technologies, the software company pioneered the development of a PC-based cost-estimating program and quickly became known for its “Costimator®” Computer-Aided Cost Estimating System. The comprehensive database inside Costimator includes manufacturing process cost models, material specifications, machine handing and labor standards which help users increase estimating speed, accuracy and consistency, while boosting efficiency and profits.

Costimator provides part supplierswith a fast, accurate, and consistent method to estimate cycle times and costs for quoting and process planning purposes; enabling estimators and engineers to bid with confidence and optimize their ability to win more profitable contracts.

OEMs (original equipment manufacturers) further utilize the core knowledgebase, from within the Costimator system, to identify and understand the cost drivers in the parts they design, manufacture and procure. By breaking down and quantifying the true costs of manufactured parts and assemblies, Costimator allows companies to implement uniform and predictable costing strategies while reducing cost throughout the product lifecycle. The estimating software enables procurement teams to determine the actual cost of manufacturing parts, proven to help reduce costs by as much as 50%.

A Should Cost Estimating Service (SES) was formed in 2006 by MTI Systems, to help meet the ever-increasing demand for outsourced manufactured parts and cost engineering services by OEMs.

Estimators and engineers, at MTI Systems, utilize their extensive estimating expertise and the Costimator software, to provide detailed part cost analysis. This combination helps to identify and implement cost reduction opportunities and strategies throughout the product development lifecycle.

Today, with thousands of users worldwide, the cost estimating tool is utilized by many Fortune 500 companies helping to increase their manufacturability and competitiveness. Companies of all sizes, use Costimator, to help them manufacture and produce parts and products in nearly every industry sector, including aerospace, electronics, automotive, heavy equipment, medical and consumer products.

“30 solid years of helping estimators produce fast and consistently accurate estimates and we are proud of our long-standing history,” remarks Mr. Tom Charkiewicz, founder and CEO of MTI Systems. “Software technology continues to advance which affords us great opportunities in developing new products and services to meet not just today’s ever-increasing need for effective cost reduction strategies but the for the future, as well!”

MTI Systems, Inc. is a world-leader in the development of innovative cost-estimating software and

Article source: Source

FDA NEWS RELEASE

Company failed to correct violations despite federal, state warnings

January 31, 2012 (MMD Newswire) — The U.S. Food and Drug Administration is asking a federal court to prevent a New York cheese manufacturer from operating because of a history of unsanitary conditions and producing cheese in a facility contaminated with Listeria monocytogenes bacteria.

According to a complaint for permanent injunction filed by the U.S. Department of Justice, Mexicali Cheese of Woodhaven, N.Y., and two of its officers, Edinson Vergara and Claudia Marin, produced cheese under persistent unsanitary conditions that contributed to widespread Listeria monocytogenes contamination in Mexicali Cheese’s facility.

In addition, the complaint, filed January 30 in the U.S. District Court for the Eastern District of New York, says that the New York State Department of Agriculture Markets, Division of Milk Control and Dairy Services found similar unsanitary conditions in addition to product contamination.

Mexicali Cheese makes and distributes a variety of soft Mexican cheeses to grocery stores and supermarkets in New York, New Jersey and Connecticut. Mexicali Cheese’s products include queso fresco [fresh cheese], queso oaxaca [Oaxacan cheese] and queso para freir [cheese for frying].

If entered by the court, the injunction would stop the company and its officers from manufacturing and distributing food until they can bring their operations into full compliance with the Federal Food, Drug, and Cosmetic Act and FDA food safety regulations.

“FDA filed this complaint to protect the health of consumers,” said Dara A. Corrigan, associate commissioner for regulatory affairs. “Working closely with New York’s Department of Agriculture and Markets, we took this step to ensure that consumers do not eat potentially dangerous foods from this company.”

Consumers can report problems with FDA-regulated products to their district office consumer complaint coordinator.

The FDA, an agency within the U.S. Department of Health and Human Services, protects the public health by assuring the safety, effectiveness, and security of human and veterinary drugs, vaccines and other biological products for human use, and medical devices. The agency also is responsible for the safety and security of our nation’s food supply, cosmetics, dietary supplements, products that give off electronic radiation, and for regulating tobacco products.

Source: FDA

Article source: Source